​

Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Lexicon Pharmaceuticals Ownership Summary


Lexicon Pharmaceuticals is owned by 91.58% institutional investors, 1.12% insiders, and 7.30% retail investors. Artal group is the largest institutional shareholder, holding 43.76% of LXRX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.64% of its assets in Lexicon Pharmaceuticals shares.

LXRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLexicon Pharmaceuticals91.58%1.12%7.30%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Artal group175.16M43.76%$420.37M
Fmr51.78M12.94%$124.28M
Siren44.30M11.07%$106.33M
Sessa capital im18.96M4.74%$45.51M
Blackrock funding, inc. /de17.35M4.33%$41.64M
Blackrock9.89M4.03%$16.62M
Vanguard group9.61M2.64%$11.05M
Vanguard capital management9.90M2.47%$23.76M
Point72 asset management8.25M2.06%$19.80M
Geode capital management6.24M1.56%$14.99M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Artal group175.16M45.15%$420.37M
Siren44.30M2.15%$106.33M
Sessa capital im18.96M0.76%$45.51M
Virtus investment advisers170.41K0.10%$409.00K
Adar1 capital management750.00K0.08%$1.80M
R squared54.98K0.07%$131.96K
Gsa capital partners llp397.22K0.06%$953.00K
Ikarian capital164.67K0.04%$395.22K
Headlands167.20K0.04%$401.27K
Diker management20.00K0.04%$48.00K

Top Buyers

HolderShares% AssetsChange
Artal group175.16M45.15%20.42M
Blackrock funding, inc. /de17.35M0.00%14.03M
Fmr51.78M0.01%6.73M
State street4.92M0.00%3.95M
Geode capital management6.24M0.00%3.08M

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---11.02M
Millennium management1.13M0.00%-3.81M
Nea management company---2.38M
Marshall wace, llp---2.38M
Ameriprise financial---2.33M

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company1.96M0.00%1.96M$4.70M
Nuveen586.66K0.00%586.66K$1.41M
Janney montgomery scott295.55K0.00%295.55K$709.00K
Canada pension plan investment board257.90K0.00%257.90K$618.96K
Rhumbline advisers256.88K0.00%256.88K$616.52K

Sold Out

HolderChange
Ifp advisors-1.00
True wealth design-2.00
Newedge advisors-5.00
Federated hermes-6.00
Capital performance advisors llp-18.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261549.22%366,550,07613.35%911.40%8316.90%3633.33%
Mar 31, 20261377.87%322,086,78123.68%881.73%6836.00%27-32.50%
Dec 31, 202531-76.15%15,205,811-94.10%40.08%7-85.11%8-80.00%
Sep 30, 202548-60.66%14,323,194-94.37%30.08%11-81.03%15-57.14%
Jun 30, 2025126-3.82%256,258,970-3.59%701.31%59-11.94%3818.75%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O20.40M5.64%2.23M
Fidelity Growth Compy Commingled Pl S24.67M5.55%838.50K
Fidelity Growth Company Fund17.25M3.88%705.64K
Vanguard Morn Total Stk Mkt Idx Investor7.08M1.59%236.20K
Vanguard Total Stock Mkt Idx Inv7.08M1.59%236.20K
Vanguard MStar Total Stk Mkt Idx Invest7.08M1.59%-
iShares Russell 2000 ETF6.19M1.39%-109.82K
Fidelity Growth Company K65.08M1.14%195.76K
Vanguard US Total Market Shares ETF3.89M1.08%-
Fidelity Series Growth Company4.13M0.93%149.60K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 25, 2026DEBBANE RAYMOND-Buy$2.98K
Feb 23, 2026DEBBANE RAYMOND-Buy$147.00K
Feb 20, 2026DEBBANE RAYMOND-Buy$147.79K
Feb 19, 2026DEBBANE RAYMOND-Buy$71.97K
Feb 18, 2026DEBBANE RAYMOND-Buy$176.47K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q18-
2025 Q2--
2025 Q1--
2024 Q4--

LXRX Ownership FAQ


Who Owns Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals shareholders are primarily institutional investors at 91.58%, followed by 1.12% insiders and 7.30% retail investors. The average institutional ownership in Lexicon Pharmaceuticals's industry, Biotech Stocks , is 380.48%, which Lexicon Pharmaceuticals falls below.

Who owns the most shares of Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals’s largest shareholders are Artal group (175.16M shares, 43.76%), Fmr (51.78M shares, 12.94%), and Siren (44.3M shares, 11.07%). Together, they hold 67.77% of Lexicon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Lexicon Pharmaceuticals?

Yes, BlackRock owns 4.03% of Lexicon Pharmaceuticals, totaling 9.89M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.62M$. In the last quarter, BlackRock increased its holdings by 2.2M shares, a 28.56% change.

Who is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Artal group is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 45.15% of its assets in 175.16M Lexicon Pharmaceuticals shares, valued at 420.37M$.

Who is the top mutual fund holder of Lexicon Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Lexicon Pharmaceuticals shares, with 5.64% of its total shares outstanding invested in 20.4M Lexicon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools